While each individual situation varies based on factual circumstances and market dynamics, generally, we consider: y Value provided to patients y Value provided to health care systems y Unmet need y Access y R&D sustainability y Competition We have a long history of making our medicines and vaccines accessible and affordable through responsible pricing practices and industry-leading patient access programs.